NKTR didn't disclose the total number of patients treated with NKTR-214 + Opdivo, or the total number of such patients who have responded (of which none has relapsed). However, it ought to be not too hard to come up with a rough estimate of these numbers.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.